Survey far the establishment of imaging procedure guideline using EBM approach by 高橋 雅士 et al.
EBMを用いた放射線診断のガイドライン作成に関す
る研究
著者 高橋 雅士, 村田 喜代史, 新田 哲久, 高櫻 竜太郎
発行年 2005-06
その他の言語のタイ
トル
Survey far the establishment of imaging
procedure guideline using EBM approach
URL http://hdl.handle.net/10422/3693
?
?
?
??ゅ
研究成果報告書
EBMを用いた放射線診断のガイドライン作成に
関する研究
(14570851) 
平成 14年度'"'-'16年度科学研究費補助金(基盤
研究C2)
平成 17年 6月
研究代表者 高橋雅士(滋賀医科大学医学部)
じ盗量塾天手雨麗函言語寸????????????????
2004011505 
研究組織
研究代表者
研究分担者
研究分担者
研究分担者
交付決定額(配分額)
平成 14年度
平成 15年度
平成 16年度
総計
研究発表
( 1 )学会誌等
高橋雅士
村田喜代史
新田哲久
高棲竜太郎
直接経費
1， 300千円
500千円
600千円
2，400千円
(滋賀医科大学・医学部、助教授)
(滋賀医科大学・医学部、教授)
(滋賀医科大学・医学部、助手)
(滋賀医科大学・医学部、助手)
間接経費 合計
0千円 1， 300千円
0千円 500千円
0千円 600千円
0千円 2， 400千円
高橋雅士、村田喜代史、新田哲久、'高棲竜太郎、西本優子、藤野昇三、中野恭幸
肺癌(非小細胞癌)の遠隔転移診断 -E即時代における画像検査一
画像診断23(5):509-517， 2003. 
Takahashi M， Murata K， Nitta N， Takazakura R. 
How should CT be used in the management of communi ty acquired pneumonia (CAP)? : Survey 
of previously published articles. 
(To be submitted) 
高橋雅士、新田哲久、高桜竜太郎、牧大介、村田喜代史 胸部単純 X線写真の基礎 ど
う写っていれば正常? 臨床面像 20 No.4増刊号胸部画像診断:これだけ押さえれば大
丈夫 4-20、2004.
新田哲久、高橋雅士、高桜竜太郎、永谷幸裕、牧大介、村田喜代史、(放:滋賀医大)、
松尾寿保(放:公立豊岡病院) 肺癌 画像診断はここまできた 肺結節の定量的評価ーソ
フトウエアの評価を中心にーDIGITAL MEDIClNE 4(6) 2004 
村田喜代史、高橋雅士
肺癌診療ガイドラインをめぐって:肺癌の画像診断
MEDICO 35(5) p161-164 2004.5 
高橋雅士、藤野昇三: 外科医の求める画像診断:呼吸器.臨床画像20: 1200-1207 2004. 
高橋雅士、新田哲久、高棲竜太郎、永谷幸裕、牧 大介、村田喜代史:コンヒ。ュート断層世代
の単純X線と透視の知識.胸部単純X線撮影 もう一度見直そう、胸部単純X線写真の意
義.臨床画像 20;1250-1260，2004. 
村田喜代史 呼吸器疾患の画像診断肺癌の画像診断の進歩
呼吸と循環 52(12) :1285-1289 2004 
村田喜代史、高橋雅士、新田哲久、高桜竜太郎、牧大介
肺癌の画像診断の進歩 肺癌診断のストラテジー
Medical Practice 21(8) p1255-1259 2004.8.1 
新田哲久、高橋雅士、高桜竜太郎、永谷幸裕、牧大介、村田喜代史、
牛尾哲敏(放)、伊藤俊英(シーメンス旭メディテック株)
胸部読影支援シーメンスソフトウェアの使用経験について Rad Fan 3(3) :63-65 2005 
新田哲久、高桜竜太郎、永谷幸裕、牧大介、牛尾徹敏、
高橋雅士、村田喜代史(放)、津田川勝(立大理工・電気電子工学)
肺癌の画像診断 MDCTによる肺癌診断の進歩 (CADを含めて)
Radiology Frontier 08(02) :95-99 2005.5 
( 2 )口頭発表
高橋雅士 リフレッシャーコース、肺癌検診、スクリーニングから生検へ
第 39回日本医学放射線学会秋季臨床大会、 2003年 10月 11日(神戸)
村田喜代史 肺ガン画像診断のガイドラインについて
高橋雅士 胸部X線写真の読影について
第 61回滋賀呼吸器疾患懇話会 2004.6.10 草津
村田喜代史 肺癌画像診断の現状と将来 第 76回北九州肺縦隔疾患研究会 2004.11. 5 
北九州
村田喜代史 肺癌画像診断の現状と将来 第 3回福井県肺癌検診従事者研修会
2005. 2. 20 福井
(219回福井県胸部疾患研究会)
村田喜代史肺癌画像診断における現状と将来
第3回大分肺癌セミナー 2005.2.22 大分
Maki D.・TakahashiM. • Takazakura R. • Ni tta N. • Murata K.， Sawai S.・TezukaN. • 
Fuj ino S. • Inoue S. 
BRONCHOGENIC CARCINOMA ASSOCIATED WITH BULLOUS LUNG 
DISEASE:CT APPEARANCES AND PATHOLOGICAL CORRELATIONS 
1ST WORLD CONGRESS OF THORACIC lMAGING AND DIAGNOSIS 
IN CHEST DISEASE 2005.5.7-10 Florence， Italy 
( 3)出版物
高橋雅士 W肺癌および肺良性腫療 2.肺門部肺癌 p106-125 村田喜代史、上甲剛、
池添潤平編 胸部のCT第二版 メディカノレサイエンスインターナショナノレ東京
2004年
村田喜代史
III 胸部画像診断 1.胸部 X線写真と CT，MRI 和田洋巳・三嶋理晃編 呼吸器病学総合
講座 p50-59 2004. 7. 10 メディカノレレビュー社 大阪
高橋雅士
III 胸部画像診断 2.胸部疾患の画像診断の進め方肺野病変 縦隔病変 和田洋巴・三
嶋理晃編呼吸器病学総合講座 p61-71 2004. 7. 10 メデイカルレビュー社大阪
Repo凶 ofthe research supported by Japan Society for the Promotion 
of Science: Grant-in-Aid for Scientific Research(C) 14570851. 
(2002-2004) 
Research Title: 
Survey for the Establishment of Imaging Procedure Guideline using 
EBM Approach 
Principle investigator: 
Masashi Takahashi， M.D. Shiga University of Medical Science 
EBM (Evidence Based Medicine) was :first proposed by Guyatt GH in 1991 and has 
been widely accepted in the medical :field during past decade. EBM . is conducted using the 
following :five steps; 1. Asking Ai1swerable Questions 2. Finding the Best Evidence 3. Critically 
Appraising the Evidence 4. Acting on the Evidence 5. Evaluating your Performance. On the 
other hand， many clinical guidelines have already been published. Recently， the establishments of 
these guidelines紅eusually based on the EBM approach. In J apan， the in廿oductionof EBM 
approach in establishing clinical guideline was strongly recommended by Minis句，of Health， Labour 
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and Welfare. However in the field of radiology， especially the diagnostic imaging， the use of EBM 
approach is not sufficiently used and the comprehensive clinical guideline has not been published. 
Thep町poseof this study is to collect the basic information regarding EBM approach of diagnostic 
imaging， especially in仕lefield of chest radio1ogy. The study is composed of two main categories; 
A) diagnostic guide1ine of the search for the metastasis in the cases with non-small cel 
bronchogenic carcinoma， B) diagnostic guide1ine of the imaging for the community acquired 
pneumoma 
A. diagnostic guideline of the search for the metastasis in the cases with non-small cel 
bronchogenic carcinoma 
A-1. Introduction 
The prognosis of bronchogenic carcinoma is usually defmed by the 10ca1 con仕01rate， as
well as，由emanagement of distant metastases. It is widely accepted that仕leincidence of 
metastasis in the cases with bronchogenic carcinoma is ex仕eme1yhigh if compared to other types of 
malignancy. Auerbach et al(l) has reported the incidence of distant metastasis based on the 662 
autopsy cases in which it was observed that metastaseis to the brain， adrena1 gland and bone were 
observed in almost 30-50% of cases including the microscopic diagnosis. Q山ntet al. has reported 
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that the metastases wぽefound on imaging diagnosis in 72 of 348 cases(21 %) with bronchogenic 
carcmoma. 百回org組 metastasizedwere markedly varied as following; br出1(65.2%)， bone(50%)， 
1iver(30.6%)， adrenal gland (20.8%)， body wall(l8.1%)， lung(15.3%)ョ spleen(8.3%)，abdominal 
LN(8.3%)，砿illaryLN(5.6%)ラ spinalcord (4.2%)， pancreas (1.4%)(2). 百lesmall lung cancers 
have become 合equentlyfound probably because of the improvement of imaging diagnosis. The 
risk of distant metastases of these c，mcers釘econsidered to be low. However， Jung et al(3) h出
reported也at90 cases with Tl NSCLC have revealed也at13%(12/90) already had the distant 
metastasis at the initial establishment of diagnosis and newly developed metastases were observed at 
1 ye訂 followup in 11%(10/90). Therefore， even with the small lung cancer， the risk of distant 
metastasis is stil a significant proble，1l. On the other hand， the validity of the variable medical 
procedures are now re胴evaluatedusing the EBM technique. M勾orreason for由istendency is the 
high medical cost in advanced nations and the increased interests of the population toward the 
quality of the medicine. The appropriateness of the methods to search the metastatic lesion in the 
cases wi也 lungcancer is also debated企omthe EBM aspect. In this study， the validity of the 
procedure for searching metastatic lesion in the cases with NSCLC will be reviewed. 百le
following two m勾orguideline regarding仕leclinical practice of bronchogenic carcinoma have 
already been published; ASCO(American Society of Clinical Oncology): Unresectable non-small 
cel lung cancer(1997)(4)， ATSARS(American百lOracicSociety厄uropeanRespiratory Society): 
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Pre仕eatmentevaluation of nOIトsmal1蝿ce111ungcancer(5). Also in Japan，仕leclinica1 guideline of 
出elung cancer with using EBM procedぽewas recently published(6). In this review， the 
guidelines of these m勾orEnglish pUlblications wil1 be mainly introduced. The level of evidence 
and the level of the recommendation which used in the guideline of ASCO紅eshown in table 1 and 
2. 
A-2. Importance of clinical picture!i 
Recently， two meta-analysis have been published regarding the search for the metastatis in 
the cases with bronchogenic c訂cinoma(7，8). According to these articles， although the concept or 
the method to search the metastatic lesion紅emarked1y varied among the institutesラitis noted that 
every guideline emphasize the importance of clinica1 pictures of the patients before performing the 
examination of metastatic lesion. If the patient does not demonstrate any subj ective symptoms， the 
possibility of the metastasis is extremely low. Silves出 eta1. have reported that也enegative 
predictive value of the c1inica1 pictures regarding brain， abdomen and bone metastases紅eextremely 
high， 95%，94% and 89%， respectively(8). On the other hand， the imaging moda1ities訂e企equently
used regardless with the patient symptoms to search the metastatic lesions in J apan. Table 3 shows 
出estandard c1inical examination and signs suspected to have metastasis in the cases with 
bronchogenic caτcmoma. 
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A-3. BraIn 
ASCO: Head CAT or brain MRl with and without infusion of con仕astmaterial should be obtained 
only in patie国swho have signs or symptoms of CNS disease. (Level of evidence I， grade of 
recommendation B) 
ATSARS: The recommendation is to perform head CT only in patients with newly diagnosed 
NSCLC who have positive findings on clinical evaluation or in patients with nonspecific findings 
也atsuggest widespread disease， ifmetastatic disease has not been documented elsewhere. The use 
of routine MRl of the head has not been adequately studied and is not recommended at this time. 
The incidence of distant metastasis is increased when the加morsize exceeds 3cm， 
especially in adenocarcinoma(8，9).百leincidence of discove由19metastatic foci in the cases with 
respectable lung cancer without symptoms間 generally3ぬ 8%(10，1). 百lemost important issue 
is whether the imaging procedures to search metastatic lesion should be performed for al the 
patients with lung cancer or not. 
In most of the institutes il J apan， brain CT or MRl釘ecOllsidered as a routine imaging 
procedure as a preoperative evaluatioll. The results of followillg articles訂econsistellt with these 
仕ends. Ferringno et al have performed retrospective comparative study il which the clinical 
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significance of brain CT as a preoperative evaluation for the 184・newlydiagnosed patients with 
NSCLC(12). In this study， the cases that neurological symptoms appe紅edwithin 6 months after 
CT were considered as true positive， and the cases whose CT were normal and no neurological 
symptoms at 12months follow up after the CT were considered as仕uenegative.百leobtained 
sensitivi守ラ spec出cityand accuracy were 92%， 99% and 98% respectively. There was no 
relationship between the existence of neurological symptoms and that of brain metastasis. Among 
the 25cases with positive CT findings， 16 cases did not demons仕ateany neurological fmdings(64%). 
Among 31 patients with respectable hmg cancers， 3 c部es(lO%)were proven to have brain met剖tases.
From these data， they have concluded that brain CT should be performed in al the patients with 
resectable lung c組問. Butler et al. also supported this opinion from the aspect of cost-benefit(11). 
Earnest et al(9). have executed the brain MRl with con仕astfor the 27 patients witl NSCLC staged 
more than TlNOMO and observed whether the newly metastasis has appeared during 12 months 
follow up or not with comparison to也e1 0 patients to whom MRls were not performed. Among 
也emラ 22%of patients(6/27) were proven to be brain metastases and they were企eefrom 
neurological symptoms. No false positive was found in the cases with contrast MRl group and 
there was no newly appeared brain metastasis observed dur也g12 months in社lepatients whose 
initial MRl did not show組yabnormality. According to these resultsラitcan be concluded that MRl 
with con回 stshould be performed as the pre-operative examination. 
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On the other hand， there are a lot of manuscripts which insisted也atit is questionable to 
perform imaging s阻dyfor血epatients without any neurological symptoms. Silves仕iet al(8). have 
reported that the incidence of discovering brain metastasis in the cases with asymptomatic NSCLC 
were on1y 3 % and仕lenegative predictive value of neurological symptoms are extremely high as 
95%. Cole et al(13). have reported that brain CT with con甘astfor 43 NSCLC patients without any 
neurological symptoms did not any imaging findings suggesting brain metastases. Among them， 
30 MRI wi血 contrastwere also performed， however no additional information were obtained. 
These authors have negative OpiniOXlS for the use of CT or MRI if the patients are neurologically 
normal. 
Low specificity of the brain CT as a preoperative evaluation was indicated by Patchell et 
al.(14) Among the fi向イourcases in whom the solitary mass 1esion was found on pre叩 eratIve
CT examination for ma1ignancy including lung cancer， 6 cases(ll %) we問 provento be 
non-metastatic 1esion such as primary brain tIlmor， brain abscess or non-specific inf1ammation. 
The re1ationship between the incidence of brain metastasis and metastasis to other organ 
was discussed in a several papers. Kormans et al.(15) have reported出atamong 158 cases with 
asymptomatic NSCLC， pre・operativeCT have found 6 brain masses including 5 cases of metastases 
and 1 case with glioma. 12 months follow up has revea1ed 5 cases wi也brainmetastases， most of 
which紅eN2 cases and adenocarcinoma. Therefore they have concluded that brむnCT shou1d be 
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performed as a pre-operative examination if the histology is adenocarcinoma associated with 
high-grade N factor. Grant et a1.(16) analyzed the findings of chest， abdomen and brain CT in 114 
resectable NSCLC. Among 10 cases with brain metastases， 9 cases simultaneously demons仕ated
metastases to mediastinal lymphnodes or abdominal organ. Among the 9 cases with abdominal 
metastases， 7 cases were combined with brain of mediastinal lymphnode metastases. Brain 
metastases are strongly related with the metastases to ex仕acr創ualmetastases and pre-operative 
comprehensive research will prevent the unnecessary operation. 
From the cost欄benefi.taspect， Colice et al.(l7)， wi吐1decision analysis model， have 
compared the cases with routine use of brain CT and the cases in whom the CT isindicated on1y the 
neurological symptoms are observed. They found the poor cost-benefit ratio in the former cases. 
The diagnostic capability was compared between the CT and M則 bya several authors. 
Kumasaki et a1.(l8) have studied 218 lung cancer cases and 38 cases with brain metastases were 
found. Among them， 24 cases to whom the CT and MRl were simul加leouslyperformed were 
selected and detectability of the metastases were comp紅ed. In 24 cases that con位astMRl showed 
brain metastasis， CT could not detect met剖t郡白血7patients. Yokoi et a1.(19) have compared the 
usefulness of MRl佃dCT in the detection of brain metastases during preoperative evaluation and 
postoperative followべlp.Of 332 patients with potentially operable NSCLC who were企eeof 
neurological s屯nsand symptoms， brain CT was performed preoperatively on 155 patients (CT 
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group) and brain MRI on 177 patients (1凪1group). Patient characteristics in both groups were 
comparab1e. In 279 patients with complete resection of the primary lung知mor，intensive 
follow-up with CT and MRI was performed in the respective groups. The preoperative detection of 
brain metastases， postoperative intracrania1 recurrence rates， and characteristics of detected brain 
tumors were compared between the two groups. The survival of patients with brain metastases was 
also compared. Results: From the frst eva1uation to 12 months a:fter s町geryfor prim訂ylung cancer， 
brain metastases were observed in 1 patients (7.1 %)企omth巴CTgroup and 12 patients (6.8%)企om
the MRI group. MRI detected brain metastases preoperatively in 6 of the 12 patients (3.4% of the 
total MRI group)ラwhereasCT detected brain metastases preoperatively in 1 ofthe 1 patients (0.6% 
ofthe加ta1CT group). MRI showed a tendency toward a higher preoperative detection rate of brain 
metastases than CT (p = 0.069). F町也ermore，the mean (+/・ SD)max.ima1 diameter of伽 brain
metastases was significantly smaller in the MRI group (12.8+ん9.1mm) than in the CT group 
(20.3+/・7.0mm) (p = 0.041). However， the median surviva1 time and 2-year s町viva1rate a:fter 
仕切出.entof detected brain metastases， respectively， were 10 months and 27% in the CT group and 
17 months and 28% in the MRI group. There was no significant difference between the groups in 
survival time. From these data，仕leyconcluded出atpreoperative eva1uation and intensive follow-up 
with MRI could facilitate early detection of brain metastases in patients with potentially operable 
lung c組問工
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Regarding the post-operative follow up， Yokoi et al. (20) s加died128 patients with 
completely resected non-small cel lung cancer. Follow-up computed tomographic scans were 
obtained eveη2 to 6 months over 24 postoperative months in 69 patients and eveη2 months for 6 
postoperative months in 59. Brain metastases were discovered in 1 patients (8.6%)， and 7 patients 
were neurologically asymptomatic when the metastases were diagnosed. Single metastasis was 
found in 5 patients and multiple metastases in 6. The maximal size of al but one lesion was less 
than 25 mm. The median survival time and 5-year survival rate in al 1 patients with brain 
metastases were 10 months and 24%， respectively. Furthermore， those in 7 asymptomatic patients 
were 25 mon仕lSand 38%， respectively. They have concluded that intensive follow-up with 
computed tomography to be worthwhile for early detection and e:fective tr何回.entof brain 
metastases in patients with completely resec凶 lungcancer. 
A-4. Bone 
ASCO: A bone scan should be performed on1y in patients who complain ofbone pain， chest pain， or 
who have an elevated serum calcium level or an e1evated serum alkaline phosphatase leve1. (Level of 
evidence II， grade of recommendation c) 
ATSASR: Any one of the following findings are presented in patients with NSCLC should prompt a 
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radionuclide bone scan; common clinical fmdings of bone metastases include bone pain， pa.tho10gic 
企actures，and/or an e1evated alkaline phosphatase or serum calcium 1evel. If the c1inical evaluation 
is negative， a radionuclide bone scan should not be performed. If a radionuclide scan shows 
mu1tip1e areas of uptake consistent with metastase， no fi町出ereva1uation is necessary. An iso1ated 
ぽeaof uptake may require further evaluation. 
Bone metastases are found in 9・15%of patients with new1y diagnosed NSCLCο1，22). 
The spine is a predominant site and the histo1ogy of adenocarcinoma and coexistence with a 
metastasis to medias由lal1ymphnodeare the predisposing factors. Bone scintigraphy is considered 
as the most sensitive method， however the re1ative1y high rate of fa1se positive is a m句orconcem.
Miche1 et al.(21) prospective1y s卸died1 0 consecutive patients referred for initial staging 
ofnon圃smallcell1ung cancer and assessed the sensitivity of a group of clinical indicators (chest pain， 
ske1eta1 pain， bone tendemess on physical examination， serum alkaline phosphatase， and serum 
ca1cium) for the presence of skeletal metastases as determined by bone scanning. The final staging 
result was validated with follow up data over at 1east three years. At the i出tia1staging 37 of 1 0 
bone scans (34%) showed areas of increased uptake， of which only nine were confrrmed to be 
metastases (by tomography， computed tomograph:王町biopsy).Halfthe pa討ents(55) had at 1east one 
clinical indicator suggesting ske1etal metastases， inc1uding al patients with proved ske1etal 
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metastases. Thus the sensitiviけ ofthese clinical indicators was 100% and也especificity 54%. 
Wi白moneye紅 threeof 27 patients with non-conf・irmedpositive bone scans had skeletal metastases， 
one of which was in the紅eathat had shown increased uptake initialy. All these patients had clinical 
indicators for skeletal metastases and al had inoperable advanced旬mours.Four of 69 patients with 
an initially negative bone scan developed skeletal metastases within one year. From these resultsラ
they have concluded出atin nOIトsmal1cel lung cancer bone scanning can be restricted to patients 
with clinical indicators for skeletal metastases(23，24). 
A酬5.Adrenal gland 
ASCO: The finding of an isolated adrenal mass on ul仕asoundor CT requires biopsy to ru1e out 
metastatic disease if也epatient is considered to be potentially respectable. (Level of evidence II， 
grade of recommendation c) 
ATS/ERS: CT of the thorax should include the adrenals. Con仕astadminis仕ationis not required. 
Biopsy should be performed in any i.ndeterminate adrenal mass that is not shown to contain fat by 
either CT or MRl. 
Adrenal metastasis is found in 18-38% of the patients with lung cancer (25). However the 
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almost twかthirdsof adrenal masses ob田町edin the cases with NSCLC are adenoma. Oliver et 
al(26)佃 dEttinghausen et al.(27) have reported the simi1ar results; a1though the adrenal masses were 
found 7.5%釦 d4.1% of330 and 243 cases with NSCLC， respective1y， metastases were proven only 
2.4%佃dl.6%， respective1y. Gillams et al.(28) found 22 cases(4%) wi也 adrena1masses in 546 
1ung cancer patients， and among them， only 5 cases were proven to be metastases. Si1verman et al. 
reported the accuracy of96% ofpercutaneous biopsy for adrenal mass(29). 
1t is indispensab1e to consider the technical performance of CT scanner if the indication of 
CT to the adrenal is discussed. As a recent fast CT scanner， such as MDCT， made it possib1e to 
cover the wide釘eaof the body with thin slice and a short time， whether the 1eve1 of adrenal should 
be covered or not is no-1onger unimportant issue. However， the following articles which pub1ished 
almost one decade before were discussing the clinical significance of adrena1 CT as an independent 
procedure. Si1vestri et al. (30)s加died173 patients with 1ung cancぽ andreviewed abnorma1ities in 
せrreeclinica1 categories (signs， s戸nptoms，and routine 1aboratory tests) and the presence of 
ex仕ap叫mon釘y加morspread inc1uding adrenal invo1vement by CT. They found that adrenal 
metastases抗 foundin patients with a 1arge加morburden who have c1inical indicators of 
widespread disease. There is no evidence of adrenal metastases by CT in any patient wi也 anormal 
clinical evaluation. 1t is concluded也atCT scans through the adrenal glands紅eunnecess釘ywhen
staging newly diagnosed bronchogenic carcinoma if the白ldings企omthe initial clinical evaluation 
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紅enormal. Eggesbo et al. (31) have surveyed the CT scans of brain， chest and abdomen which 
were performed on 96 patients with lung cancer， and evaluated the correlation with the incidence of 
adrenal mass， TNM staging， and histology. Most of the patients with adrenal metastases showed 
distant metastases to non-adrenal gland or advanced nodal metastases. Therefore， routine CT 
examination of adrenal gland has no clinical significance. 
B町tet al.(32) have evaluated the accuracy of magnetic resonance imaging in 
distinguishing a benign企oma malignant adrenal mass in patients with otherwise operable NSCLC. 
The higher signal than the liver or con仕alateral adrenal is considered as metastases. The result 
showed that the false-negative rate was 0% and the false-positive rate was 67%. They have 
concluded that most adrenal masses in patients wi仕1operable NSCLC are benign and currently 
available magnetic resonance imaging methods cannot replace biopsy. Porte et al.(33) have 
reported the similar tendency of MRI and stated that 100% of sensitivity and specificity can be 
achieved by CT guided biopsy. The detection of fat within the adrenal mass is markedly significant 
when the adrenal mass is encountered. McNicholas et al.(34) have suggested that ， for the 
management of adr叩 almass les than 5cmヲ if白eCT value is les than OHU， itshould be 
diagnosed as adenomaョぜか20HU，chemical shift MR imaging should be performed， and正more
せ1阻 20HU，biopsy should be performed. From the cost-benefit analysis， Remer et al.(35)， with 
using decision analysis model， showed that the criteria of les than 10HU is jusぽiableto diagnose 
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adenoma and chemical shift imaging should be used as an additional option. 
A-6. Liver 
ASCO: The finding of an isolated hepatic mass on ultrasonographic or computed tomographic exam 
requires a biopsy to rule out matastatic disease if the patientis otherwise considered to be potentially 
respectable. (Level of evidence II， grade of recommendation c) 
ATS厄SR:百lerole of liver imaging as pぽtof the initial staging chest CT for the detection of liver 
metastases is con甘oversial.Most liver lesions are benign， and contrast is required to discriminate 
benign lesions， such as cysts and hemangiomas，企ommetastatic tumor. Standard contrast.引 llanced
CT requires ex仕ascanning time and increased radiation dosage and is therefore not recommended if 
the clinical evaluation is negative. However， helical or spiral CT permits evaluation of both the 
thorax and the entire liver with a single bolus of contrast in a much reduced scan time. Percutaneous 
biopsy， ifclinically indicatedヲisrecommended for liver lesions suspicious for metastatic disease. 
The incidence of liver metastasis企omNSCLC is about 5% (36). Although there is some 
augments about the indication of the liver CT， the recent fast CT， including MDCT， can coverωthe 
lower edge of the liver with an additional few seconds and therefore it is meaningless to discuss its 
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indication. Remer et al. have also stated that chest CT including adrenal and liver is a standard 
protocol as a pre-operative study for lung cancer. 
A-7. Cost-benefit姐 alysis
There紅ea several important papers .published regarding也ecost-benefit analysis for the 
search for the extrathoracic metastases. 
The Canadian Lung Oncology Group (37) have tried句 clari:fy the optimal approach to 
the investigation of possible distant metastases in patients with app釘entlyoperable nOIトsmallcel 
lung cancer who do not have symptoms suggesting metastatic disease. They conducted a randomizedラ
controlled trial in也oracicsurgery services at mainly academic tertiary-and secondary-care general 
hospitals. They recruited 634 patients with app釘entlyoperable， suspected or proven non幽smallcel 
carcinoma of the lung without findings on histoη， physical examination， laboratory testing， or 
imaging suggesting ex仕athoracicmetastases. Patients were randomly allocated to receive either 
mediastinoscopy and computed tomography of the chest and then， depending on the results， 
immediate thoracotomy or bone scintigraphy and computed tomographic scanning of the head， liver， 
and adrenal glands. The relative risk of thoracotomy without cure (the combination of open and 
closed thoracotomy， incomplete resection， and thoracotomy with subsequent recurrence) in the :D叫l
investigation group versus the limited investigation group was 0.80 (95% conf・idenceinterval [CI]， 
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0.56 to l.13; p = 0.20). Fo均l-threepatients in the ful investigation group and 61 patients in the 
limited investigation group underwent a血oracotomybut subsequently had rec町 ence(relative risk， 
0.70; 95% CI， 0.47 to l.03; p = 0.07). Patients in the ful investigation group were more likely to 
have avoided thoracotomy because of ex仕athoracicmetastatic disease than those in the limited 
investiga討ongroup (22 patients versus 10 patients， respectively; relative risk， 2.19; 95% CI， l.04 to 
4.59; p value = 0.04). The total number of negative invasive tests was six in the ful investigation 
group and one in the limited investigation group (relative risk， 6.1; 95% CI， 0.72 to 5l.0; p= 0.10) 
and the total number of invasive tests， 1versus six， respectively (rela説明risk，l.84; 95% CI， 0.68 to 
4.98; p = 0.23). The ful investigation strategy cost $823 les per patient (95% CIs 2，482 to・725)
CONCLUSIONS: Full investigation for metastatic disease in patients with non-small cel lung 
cancer without symptoms or signs of metastatic disease may reduce the number of thoracotomies 
without c町e.The higher the threshold for considering symptoms to suggest metastatic disease， the 
more likely it isthat investigation will sp紅epatients futile thoracotomy. 
This conclusion is contradictory to the results in the previously published 
meta白analysis(7，8)and the statement企omASCO( 4) and ATS厄SR(5). On仕leother hand， the 
following papers were also found which support the statement of ASCO and ATS厄SR. Osada et 
al.(38)have evaluated how much time and money could be saved without compromising overall 
results in trea白19lung cancer with re仕ospectivelyevaluating 318 patients for T-and M-factors and 
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335 for N-factor. Ifbronchoscopy failed to diagnose a mass lesion believed to be malignant in x-ray 
computed tomography (CT)，血.eyproceeded to direct thoracotomy without need1e or video-assisted 
biopsy. When mediastinal nodes were negative in CT， they proceeded to direct thoracotomy without 
mediastinoscopy. They searched routinely for distant metastasis wi血brainand abdomina1 CTs and 
bone scans. Lesions suspected uf ma1ignancy in CT were pathologica11y ma1ignant in 93%. A tota1 of 
82.8% of patients with CT-negative mediastinum were without metastasis. The remainder， with 
metastasis， had a postoperative 5-year s町viva1of23.5%. Brain CT scans were positive in only 2.2%ラ
abdomina1 CT scans in 2.4%， and bone scans in 5.0%， for pぬentswith a cTl/T2 non-cN2 lesion. 
From these data，仕leyhave concluded that brain and abdomina1 CT scans and bone scans may be 
omitted for cTl/T2 and norトcN2lesions in CT. CT-negative mediastinum then leads to direct 
thoracotomy. The vast m勾orityof patients may thus undergo surgeηr earlier with less physica1 and 
financia1 burden. The c∞osはts悶av吋m略gwa出sca1culated to be 5卸9.4%pe釘:rC口Tl庁2no叩n-cN2p戸a白出er凶t，or 
US$666，815ラforpopulation evaluated based on cost-effectiveness. The similar evaluation was a1so 
executed by Tanaka et a1.(39). 百leydid are仕ospectiveana1ysis of 755 patients with non-sma11-cel 
lung cancer in clinical stage Tl・2NO between 1982 and 1996. The patients a1 had a ful series of 
imaging procedures， based on the staging protoco1. Their medica1 records were reviewed with 
respect to how 0合endistant metasta.sis was detected by these procedures and whether the patients 
showed any symptoms and laboratory abnormalities indicating ex甘athoracicmetastasis. The 
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incidence of distant metastasis detectβd by the imaging procedures was 2.1 % (nine of 419) in Tl NO 
cases and 5.4% (18 of 335)出T2 NO cases. Silent metastasis w出 foundonly in 0.5% (2 of 419) of 
the Tl NO cases and 0.9% (3 of 335) of the T2 NO cases. The cost of these staging procedures was 
approximately one million dollars. Thereforeラ consideringthe cost and time savings， staging 
procedures紅enot warranted for patients with non-small-cell lung cancer stage Tト2NO with 
negative clinical evaluations. 
A-8 Summary 
How is the imaging diagnosis used in searching for ex仕athoracicmetastases are mainly 
divided into the following two ways in English literatures. 
1)百leindication should be considered when the clinical symptoms訂esuspicious of having 
metastasis. T and N factor also influences the incidence of extrathoracic metastases， aswell as， the 
indication of imaging examination. (ASCO， ATSASR) 
2) The imaging search for ex凶 .thoracicmetastases should be performed regardless whether the 
symptoms are existed or not. (The Canadian Lung Oncology Group) 
It should be careful when considering the cost-effective analysis that state of medical 
insurance system or medical economy is markedly variable among the countries and the indication 
of the imaging evalu油onfor the metastasis in lung cancer is also different. Although the 
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diagnostic acc町 acyandits contribution to the survival rate should be considered， it is needed to 
establish the guideline with considering the variable social factors including medical insurance 
system or medical economy of J apan. 
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Table 1 Level of Evidence 
1 Evidence obtained企ommeta-analysis of multiple， well-designed， controlled studies. 
Randomized trials with low false-positive and low false-negative errors (high power) 
I Evidence obtained企omat least one well-designed experimental s同dy.Randomized trials 
with high false-positive and/or negative e汀ors(low power). 
II Evidence obtained 企om well-designed， quasi“experimental studies such as 
non-randomized， con仕olledsingle-group， pre-post， cohort， time， ormatched case-control series 
日T E吋dence企omwell.司designed，nonexperimental studies such as comparative and 
correlational descriptive and case studies 
V Evidence :from case reports and clinical examples 
Table 2 Grade ofRecommendation 
A There is evidence of勿pe1 or consistent findings企ommultiple studies of types I， II， or
IV 
B There is evidence of句'PesI， II， orIV and findings are generally consistent 
C There is evidence of types I， II， orIV but findings are inconsistent 
D There is litle or no systematic empirical evidence 
Table3 
STANDARDIZED CLINICAL EV ALUATION FOR METASTATIC DISEASE 
IN PATIENTS PRESENTING WITH PRIMARY LUNG CANCER 
Symptoms elicited in history 
Constitutional: weight loss 
Muscu1oskeletal: focal skeletal pain， chest pむn
Neurological: headaches，可ncope，selzures， ex出 mityweakness， recent 
change in mental status 
Signs found on physical examination 
Lymphadenopathy (> 1 cm) 
Hoarseness 
Superior vena cava勾なldrome
Bonetβnderness 
Hepatomegaly 
Focal neurologic signs: papil1edema 
Soft tissue mass 
Routine laboratory tests 
Hematocrit <40% in males 
Hematocritく35%in females 
Elevated alkaline phospha匂se，GGT， SGOT， calcium 
B. Guideline of the imaging for the management of community acquired pneumonia 
B-1. Introduction 
Pneumonia is stiU one of the leading cause of death not only in the developing nations but 
also in the advanced ones. Because there is a lot of influence on the healthcare and its cost， there 
have been many guidelines of communiけ acquiredpneumonia(CAP) derived企omthe EBM 
approach published through the wor1d (ト6).Although出eradiological evaluation is one of the 
important diagnostic approach for the pneumoniaョmostof those紅elimited to the chest radiography 
and the CT isnot considered as a routine technique. On the con仕ary，in J apan， the CT tends to be 
企equentlyused in daily c1inical practice and even so for the CAP. This tendency probably related to 
thel紅genumber of CT国立tsand the relatively less expensive fee for CT examinations in J apan. 
However.ラ therehave been no consensus regarding how the CT should be used for the patients 
suspected to have CAP. In this study， a re仕ospectiveartic1e s町veywas conducted with EBM 
approach against for the c1inical question " 1sCT needed for the management of CAP?円.
B-2. Materials and Methods 
To solve this c1inical question， an evaluation of previously published artic1es which mainly 
discussed the diagnosis of CAP were surveyed using the conventional EBM approach. Database 
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which we employed were PubMed(National Libraly of Medicine)企om1966 to 2004 and Ichushi 
Web basic mode version3 (Japana Cen回 RevuoMedicina)企om1983 to 2004. Re仕ievedcitations 
after inputting search terms were then仕組sferredto bibliography software (iPubMed maker 7 
version2.5， Kinichi Yokota， MD，PhD Health Care Center， Kitami Institute ofTechnology， Japan， File 
maker Pr07.0; Filemaker ，Inc). On this software， the abs仕actsof articles were browsed and the 
articles in which the diagnostic procedures or its implications for CAP were mainly discussed were 
selected. “Ab抑制 form"w郎 madeusing commercially available database so伽 rare(Filemaker 
pro 7.0， Filemaker ，Inc). "Abstract form" includes the following information; clinical qu帥 on，key
words， used database， titles of manuscript， title of journal， authors， objective of the research， design 
of research， materials， methods， assessed items， used statistical method， results， speci:fic comment 
and the evidence level of manuscript. The evidence level of the manuscript was rated as followings 
(Agency for Health Care Policy and Research (AHCPR).1992)(7); 
1a: Evidence obtained企ommeta-analysis of randomized controlled trials. 
1b: Evidence obtained企omat least Ol1e randomized controlled trial. 
2a: Evidence obtained企omat least one well-designed con仕olledstudy without randomization. 
2b: Evidence obtained企omat least Ol1e other守peofwell-designed quasi同experimentals同dy.
3: Evidence obtained企omwell-designed nonexperimental studies， such as comparative studies， 
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correlational studiesヲandcase studies. 
4: Evidence obtained企omexpert committee reports or opinions and/or clinical experiences of 
respected authorities. 
Addition to these databases， widely used guidelines through the world regarding the management for 
CAP were analyzed企omthe point of view for the imaging diagnosis of CAP. 
Analysis was executed on these abs佐actforms and previously published world-wide 
guidelines to address the following inquiries; 1) How should chest radiography(CXR) be used for the 
CAP? 2)1s CT needed to manage CAP? 3)Are there any di宜erence in terms of imaging 
diagnosis of CAP among the published guidelines? 
B-3.Results 
1. R館 ieveand selection of the紅ticles
A total of 336紅位cleswere found at 
terms "CAP and management" were put. These abs仕actdata were transfeπed to“iPubMed" maker 
and finally 76紅白leswere selected. 1n the same manner， a total of 699訂ticleswere found when 
the search terms "Pneumonia and CT" were used and 92的 cleswere selected. 京在lenthe 
term円pneumoniaand CT and management円 wereused， 48 abs仕actswere found and 9釘ticlesof 
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them were selected. When the tel祖円pneumoniaand imaging and management" were usedラ 57
abstracts were found and 9 articles of them were selected. 
A total of 4 articles were found at "Ichu-shi Web"企om1983 to 2004.Aug when the search 
terms “CAP and management" were put. However，仕lerewas no applicable articles found which 
described the imaging procedure for the CAP. No articles were retrieved when the the search 
terms "pneumonia and CT and man昭ement"or円'pneumoniaand imaging and management" were 
used 
2. Evaluation ofthe 紅白lesand its evidence levels 
A total of 186 articles were analyzed 合omthe perspective of the imaging for CAP and， as
a result， a t叫alof 34 articles in which acceptable descriptions regarding the imaging diagnosis for 
the CAP were found. The contents of these articles were summarized using the “abs回 ctform". 
The evidence levels of these articles were summarized oI1 the tablel. There have been no articles 
which could be rated above 2b. To evaluate the validation the published guidelines， the search 
terms “pneumonia and guideline and validation" were put on “PubMed". There have been o article 
found which performed a comprehensive validation for each guideline. 
3. Summary of the re出evedarticles regarding the imaging diagnosis for CAP. 
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1) Indication of chest radiography for the patients suspected to have CAP 
Most of the articles have stated that chest radiography should be obtained for al the 
patients suspected to have CAP as an initial diagnostic procedure(8).百lediagnosis of CAP isbased 
primarily on the clinical findings and conf・irmedby chest radiography(9，10). Main purpose of chest 
radiography is the evaluation whether the infiltrative shadows are present or not. The 
differentiation from viral bronchitis is extremely important because antibiotics abuse is a serious 
concern especially in the United States(3，11). 百lereforemany guidelines include the presence of 
infiltrative shadows as the essential diagnostic clue for the pneumonia(1-6，9). Another purposes of 
chest radiography includes the exclusion of other combined p叫mon紅ydiseases such as pulmonary 
embolism， congestive heart failure and bronchogenic carcinoma(9). An assessment of disease 
severity is another role of chest radiography such as ple町 aleffusion， cavity formation and 
multilobar involvement(9). In some guidelines， the indication of chest radiography is s回ctly
defined. European Respiratory Society(ERS) guideline recommends that chest radiography should 
be considered only for the severe or complicated cases to whom hospital management must be 
considered(6). The incidence of infil仕組veshadow in the patients who have symptoms consistent 
with pneumonia is on1y 3 %血 oULpatient services and 28% in ER(3，12). Many articles have 
mentioned some limitations of chest radiography for diagnosing pneumonia(9). Radiographic 
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finding is not reliable for conf・innationthe causative organism(9). Additionally， inter-and 
intra-observer variation is企equentlyobserved in the interpretation of chest radiography(9， 13). 
There is no established statement regarding how the chest radiograph should be obtained in the 
仕ea也lentprocess of CAP. Young non-smokers who釘ehealthy at aふweekfollow up visit 
generally do not need radiography to show pneumonia resolution(14). 
2) Indication of chest CT for the patients suspected to have CAP 
There have been few articles describing the indications of CT for the patients suspected to 
have CAP(8，9，15，17，18ユ0). Aliliough we have found 1 articles describing the CT indication， 
iliere have been no recommendation that CT should be used for ilie cases suspected to have 
CAP(8，9，1，13，15・21). 官官民 ofeleven articles have denied or suspended the conclusion about the 
usefulness of CT in the management of CAP(11，16，19). One article has stated that CT provides 
no use白1information in di宜'erentiatingcausative organism excepts for Pneumocystis Carinii 
pneumonia(PCP) and Mycoplasma pneumonia(19). Five articles were describing the CT 
indications for ilie patients suspected to have CAP(8，9，17，18ヲ20). 百lesear位cleshave stated that 
CT shou1d be used only for ilie cases with the comp1icated states or whose chest radiography is 
normal whi1e wili the symptoms sllspected to have pneumonia. One artic1e showed the detai1ed 
indication of CT including; 1) to differentiate p1eura11esion企ompulmonary 1esion， 2)to evaluate the 
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case whose x-ray shows suspicion of lymphadenopathy， 3)to evaluate the subphrenic disease， 4)白
evaluate the cavitary disease in early phase， 5)to evaluate the position of the chest tube and 5) to 
evaluate the chest wa11 invasion by the special orgasm such as ac白lOmycosis(20).
3) Described imaging procedures in previously published guidelines(Table 2) 
a. Japanese Respiratory Society (2000)(1) 
-Pneumonia is diagnosed by the clinical symptoms and acutely appe紅edinfil仕ative
shadow on chest radiography or chest CT. 
CーTis ex仕emelyuseful in di宜erentia:tingpneumonia from other conditions， evaluating 
the character and the extent of shadows. 
-As one of the assessment method for disease severity， the evaluation of disease extension on the 
chest radiography is employed; " mild， moderate and severe. 
同Chestradiography cannot identifシthecausative organism. CT can demons甘ates仕leea:τly and sma11 
disease or hidden disease， however the exact ro1 is not established yet. 
b. American Thoracic Society( 2001)ο) 
-All patients with CAP should have a chest radiograph to establish the diagnosis and 
性lepresence of complications(pleural effusion， m叫かlob釘 disease).
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-Standard PA and latera1 chest radiographs紅 evaluable in patients whose symptoms 
and physica1 examination suggest the possibility of pneumonia， and every effort should 
b e made to obtain this information. 
-The radiograph can be useful in di庄erentia白19pneumonia企omother conditions that 
may m1m1C 1t. 
百ーleradiographic findings may suggest specific etiologies or conditions such as lung 
abscess or tuberculosis. 
.百leradiograph can a1so ident均 coexistingconditions such as bronchia1 obs回 ctionor 
pleura1 effusion. 
-The radiograph is a1so useful for eva1uating severity of disease. 
圃Clinica1value of CT for the CAP is uncertain 
c. Infectious Disease Society of America (2000)(3) 
-Chest radiograph should be considered as a baseline assessment to substantiate 
diagnosis of pneumonia，加detectassociated lung diseases， to gain insight into 
causa託veagent， toassess severity，組das bilseline to assess response. (Grade of 
recommendation A， level of evidence I) 
Categories for ranking recommendations and quality of evidence in IDSA 
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Strength of recommendation 
A Good evidence to support a recommendation for use 
B Moderate evidence to support a recommendation for use 
C Poor evidence to support a recommendation 
D Moderate evidence to support a recommendation against use 
E Good evidence to support a recommendation against use 
Quality of evidence 
r Evidence企omat least 1 randomized， con仕olled出al
I Evidence企omat least 1 well-designed clinical出alwithout randomization 
II Evidence企omopinions of respected authorities， based on clinical experience， 
descriptive studies， orreports of expert committees 
-Clinical significance of CT isunclear.百lerDSA panel does not endorse the routine 
use ofthis technology because of the preliminary nature of the data and high cost of the 
procedure. 
d. British Thoracic.Society (2001)(4) 
. All patients refe汀edto hospital with CAP should have a chest radiograph. 
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圃百lereare no characteristic features of the chest radiograph in CAP that allow a 
conf・identprediction of the likely pathogen (recommendation level I) 
• CT lung scan may be useful in subjects where the diagnosis is in doubt (II)， but in 
general there seems litle role for CT scanning in the tisual investigation of CAP. 
Evidence level Definition in British Thoracic Society 
Ia A good recent systematic review of studies designed to answer the question of interest 
Ib One or more rigorous studies designed to answer the question， but not formally 
combined 
I One or more prospective clinical studies which illuminate， but do not rigorously 
answer， the question 
II One or more retrospective clinical studies which illuminate， but do not rigorously 
answer， the question 
Na Formal combination of expert views 
Nb Other information 
e.Canadian Infectious Diseases Society and the Canadian Thoracic Society(2000)(5) 
-Chest radiography is recommended for the routine evaluation of a patient suspected of 
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having pneumonia (I). 
-The advantage of chest radiography is that the diagnosis of pneumonia is strengthened 
(but not confrrmed) by the presence of an infil仕ate.Occasionally， information regarding 
etiology and prognosis may be obtained and altemative diagnoses may be entertained. 
-百lepanel realizes that in some instances a chest radiograph might not be obtained; for 
exampleラwhenthe patient is in a nursing home or when access to radiographic 
equipment is limited. The panel recognizes that under these circumstances a出alof
empirica1 therapy without radiographic confirmation of the diagnosis is a reasonable 
approach (II). 
-HRCT can detect additional infiltrates， however the significance of the improved sensitivity of the 
HRCT was not studied; whether this improved sensitivity made a必宜erencein the management or 
outcome of the cases remains to be determined. 
回Chestradiography is less sensitive than HRCT scans in detecting pulmon紅yinfiltrates， but the 
significance of this observぬonremains to be determined. 
Evidence level Defini討onin the Canadian Task Force on the Periodic Health 
Examination 
well-conducted randomized， con佐olledtrials constitute s仕ongor level 1 evidence 
well-designed con仕olledなialswithout randomization (including cohort and case-control 
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studies) constitute 1evel I or fair evidence 
expert opinion， case s印dies，and before-and-after studies釘e1eve1 II (weak) evidence. 
王EuropeanRespiratory Society (1998)(6) 
-Chest radiography is not recommended for血epatients with no risk factors including high age， 
alcoho1ism and a various co-morbidities. 
-Chest radiography is recommended for the patients to whom hospita1 m組 agementhas to be 
considered， including with risk factors for severity， risk factors for particular microorganism and 
fai1ure offrrst-1ine antibiotic therapy. 
B-4. Discussion 
Our紅白1es町veyhas revea1ed the following consensus in terms of imaging diagnosis for 
patients suspected having CAP. 
1. Chest radiography should be performed for the patients suspected having CAP. 
2. The diagnosis of pneumonia is estab1ished when the clinical signs and new1y 
appeared inf・i1trativeshadows紅eco-existed. 
3. There紅eno characteristic features of the chest radiograph in CAP也atal10w a 
confident prediction of the 1ike1y pathogen 
36 
4. There has been no systematic study conducted concerning the CT indication for the 
CAP. Although CT provides more detailed information than chest radiography， its c1inical 
significance is uncertain. 
1t is no doubt that chest radiography is an indispensable tool for diagnosing 
CAP. Chest radiography is less expensive and is easily available in almost al medical 
facilities. On the con仕町， in most of countries， CT is not considered as a routine workup for 
CAP. There is one manuscript企omFin1and describing the indication of CT for CAP(15). SyJjala 
H et al. have reported the usefu1ness of HRCT in diagnosing CAP(15). They compared chest 
radiographs with HRCT for 47 patients with clinical s戸nptomsand signs suspicious for CAP. 
HRCT identified al 18 CAP c田町 (38.3%)apparent on radiographs as well as eight additional cases 
(i.e.， 55.3%); P =.004.百lecorresJPonding figures for bilateral involvement were six by chest 
radiography (33.3%) and 16 by HRCT (61.5%)， P=.OOl: Chest radiography did not show changes 
P釘ticularlyaffecting the upper anc1 lower 1ung lobes and the lingula. Bronchopneumonia was 
visualized by chest radiography in al cases (61.1%) and by HRCT in 22 cases (84.6%).百le
corresponding figures for airspace pneumonia were four (22.2%) and one (3.8%)ヲrespectively.The 
use of HRCT seems to increase the number of CAP cases confrrmed by imaging and to improve the 
accuracy of diagnosing and typing of CAP. Low dose technique gives solution for radi油onexposure. 
The problem is the medical cost; $180 vs. 27$(15). 
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Although the systematic reseaτch has not been conducted in J apan， "The J apan Respiratory 
Society guideline for management of CAP in adult円 showed也atpneumonia is diagnosed by the 
clinica1 symptoms and acutely appeared infil仕組veshadow on chest radiography or chest CT(l). 
These generous acknowledgement for the use of CT in CAP in J apan guideline is specific and is 
markedly con回 stto those in western coun出es.In general， CT isfrequently used in clinical practice 
in J apan， probably due to its wide availability and low cost compared to the foreign coun出es.
According to the published data企omShrimpton et a1.(22)， almost 670000000. examinations were 
done by the approximately 20000 CT即日ts也roughthe world in 1997. Among them， a1most ha1f 
number of CT scanners in the world have been used and almost half number of CT examinations 
have been performed in Japan. According to the United Nation(23) and Nishizawa' et a1.(24)， 
number of CT units has been increased from 712 in 1979 to 11050 in 2000 in Japan. Although the 
actua1 number of CT examinations is not obtained， Nishizawa et a1. has speculated也at36550000 
examinations were performed in Japan annually(24). This is consistent with a mean of 290 
examinations per 10000 populations. In addition， there is no regulation by hea1th insurance 
system in Japan when the patient with pneumonia is subjected to CT scan. 
Pneumonia is stiUlisted as the 4也leadingcause of death in J apan regardless with the 
development ofits managing procedure(25). Pneumonia is stil considered as one ofthe dangerous 
common disease in daily clinica1 practice. In the Unite States， six million immunocompetent 
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peop1e釘esuffered企ombacterial pneumonia annually and pneumonia is 1isted as the 6也1eading
cause ofdea血(14，26). Annual1y， 2-3 million cases of CAP res叫tin'"'-' 1 0 million physician 
visits， 500，000 hospitalizations， and 45，000 deaths in the United States(3). The incidence of CAP 
也atrequires hospitalization is estimated to be 258 persons per 100，000 pop叫ationand 962 per 
100，000 pぽsonsaged >65 yeぽs(3). 百lecost of inpatient care， estimated at more then $9 billion a 
ye民 isup to 20 times higher than that of outpatient c釘e(3，27). It is estimated that抗mcre郡部20
billion $ ifthe 10st wages during admission is added(14). 百lereforethe establishment of accurate 
diagnosis and悦 a回 entfor pneumonia is crucial not only企omthe healthcare aspect but also企om
the economica1 one. The estab1ishment of the appropriate way for the imaging approach in 
pneumonia is also ex甘eme1yimportant. However， inJ apan， there has been no study of techno1ogy 
assessment regarding the cost-effectiveness of imaging diagnosis of CAP. The medical cost for CT 
examination is enormous1y 1arge and therefore there is a 10t of inf1uence on health insurance system 
in Japan. Although the DPC(Diagnosis Procedure Combination) system has been in仕oducedin
national旧世versityor hospita1 recently， the outpatient is not indicated in this system. Most of the 
initia1 diagnostic procedure for the patients suspected to have CAP including imaging procedure is 
usual1y performed in outpatient service. Therefore medica1 cost for也eoutpatient suspected to 
have pneumonia is stil the important issue. 
It is obvious that CT will provide the more detailed information也anchest radiography in 
39 
せlecase with pneumonia(15，28，29). CT has an ability to demons仕atethe subtle abnormali勿which
chest radiography cannot demons1rate(15，28，29). Some infectious disease shows speci:fic CT 
findings which helps physician in managing pneumonia(28). Additionallぁ thetechnological 
development of CT enables us to obtain a large number of thin-slice images in a remarkable short 
time. This tends to accelerate the企equentuse of CT even in the CAP management. However， 
there have been no evidence reported that CT can con仕ibute也emanagement of CAP more 
efficiently than the chest radiography alone. 1t is needed that more s出ctguideline about the use of 
CT in the management of CAP企omthe standpoint of technology assessment.百lIsis because not 
only企omthe economical aspect but also企omthe radiation concem to the patients. Nishizawa et 
al. have reported the result from the s町veyof CT practice in J apan with estimating the collective 
e宜ectivedose for the population(23). 百世ss町veyhas revealed that the CT examinations including 
chest is almost 30% of al CT examinations(23). These data means that the contribution of chest 
CT examinations in J apan for the collective e:fective dose for the population is significant. 
Although the low dose technique is q山tefeasible in chest CT for evaluating lung field， itis not 
routinely used for adults in daily practice. 
In conclusionョthisstudy has revealed出atno work with highly rated evidence has 
conducted about the use of CT for the patient with CAP. In J apan， it is needed that s出ctguideline 
for the use of CT in CAP isestablished企omthe aspects of medical cost and radiation expos町e.
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Table 1 : Evidence levels of retrieved articles(n=34) 
level of evidence Number of 
articles 
la 。
lb 。
2a 。
2b 。
3 9 
4 25 
Table2 : Comparison among descriptions regarding the imaging procedures for CAP in published guidelines 
Guideline 
Japanese Respiratory Society 
包000)
chest radiography 
#Pneumonia is diagnosed by the clinical symptoms 
and acutely appeared infiltrative 
shadow on chest radiography or chest CT. 
#The disease severity is evaluated by the 
extension of the shadows on the chest radiography 
as; " mild， moderate and severe. 
chest CT 
#Pneumonia is diagnosed by the clinical symptoms and 
acutely appeared infiltrative 
shadow on chest radiography or chest CT. 
#CT is extremely useful in di宜erentiatingpneumonia 
from other conditions， evaluating the character and the 
extent of shadows. 
#CT can demonstrates the early and small disease or 
hidden disease， however the exact roll is not established 
yet. 
?
?
???
?
??
??? ?
????
??????? ?????、 ，
?
?? 。?
Infectious Disease Association 
of America (200ω 
# All patients with CAP should have a chest 
radiograph to establish the diagnosis and 
the presence of ∞mplications (pleural e宜usion，
multi-lobar disease). 
# Standard PA and lateral chest radiographs are 
valuable in patients whose symp加ms
and physical examination suggest the possibility of 
pneumonia， and every effort should b e made to 
obtain this information. 
# The radiograph can be useful in di宜erentiating
pneumonia from other conditions that may mimic it. 
# The radiographic findings may suggest specific 
etiologies or conditions such as lung 
abscess or tuberculosis. 
# The radiograph is also use白1for evaluating 
severity of disease. 
# Chest radiograph should be considered as a 
baseline assessment to substantiate diagnosis of 
pneumonia， to detect associated lung diseases， to 
gain insight into causative agent， toassess severity， 
and as baseline to assess response. 
# All patients referred to hospital with CAP should 
have a chest radiograph. 
# There are no characteristic features of the chest 
radiograph in CAP that allow a 
confident prediction of the likely pathoεen 
#Clinical value of CT for the CAP is uncertain. 
# Clinical significance of CT is unclear. The IDSA panel 
does not endorse the routine use of this technology 
because of the preliminary nature of the data and high 
cost of the procedure. 
????
?
? ?
????????????
?
???
』
?
???
?
?
?
?
#CT lung scan may be useful in subjects where the 
diagnosis is in doubt (II)へbutin
general there seems litle role for CT scanning in the 
usual investigation of CAP. 
Canadian Infectious Diseases 
Society and the Canadian 
Thoracic Society(2000，2003) 
# Chest radiography is recommended for the routine 
evaluation of a patient suspected of 
having pneumonia (n)対.
# The advantage of chest radiography is that the 
diagnosis of pneumonia is strengthened 
(but not confirmed) by the presence of an infiltrate. 
Occasionally， information regarding etiology and 
prognosis may be obtained and alternative 
diagnoses may be entertained. 
# The panel realizes that in some instances a chest 
radiograph might not be obtained; for 
example， when the patient is in a nursing home or 
when access to radiographic 
equipment is limited. The panel recognizes that 
under these circumstances a trial of 
empirical therapy without radiographic 
confirmation of the diagnosis is a reasonable 
approach Qn)**. 
# HRCT can detect additional infiltrates， however the 
significance of the improved sensitivity of the HRCT was 
not studied; whether this improved sensitivity made a 
di宜'erencein the management or outcome of the cases 
remains to be determined. 
# Chest radiography is less sensitive than HRCT sc田1Sin 
detecting pulmonary infiltrates， but the significance of 
this observation remains to be determined. 
? ????? ??????? ?????????
?
????
? ?
??? Not described # Chest radiography is not recommended for the 
patients with no risk factors including high age， 
alcoholism and a various co-morbidities. 
# Chest radiography is recommended for the 
patients to whom hospital management has to be 
considered， including with risk factors for severity， 
risk factors for particular microorganism and failure 
of first-line antibiotic therapy. 
*Evidence level Definition in British Thoracic Society 
Ia A good recent systematic review of studies designed to answer the question of interest 
Ib One or more rigorous studies designed to a且swerthe question， but not formally combined 
I One or more prospective clinical studies which illuminate， but do not rigorously answer， the question 
III One or more retrospective clinical studies which illuminate， but do not rigorously answer， the question 
IV a Formal combination of expert views 
IVb Other information 
** Evidence level Definition in the Canadian Task Force on the Periodic Health Examination 
well'conducted randomized， controlled trials constitute strong or level 1 evidence 
well'designed controlled trials without randomization (including cohort and case'control studies) constitute level I or fair evidence 
expert opinion， case studies， and before'and'after studies are level III (weak) evidence 
